Browsing Tıp Fakültesi by Subject "Ovarian Cancer"
Now showing items 1-7 of 7
-
The association between the preoperative prognostic nutritional index and the controlling nutritional status score on tumor stage, chemotherapeutic response and overall survival in ovarian cancer
(Routledge Journals, 2022)Objective: This study aimed to investigate the association between preoperative prognostic nutritional index (PNI) and controlling nutritional status (CONUT) scores on the stage of ovarian cancer (OC), chemotherapeutic ... -
Clinical value of FDG PET/CT in the diagnosis of suspected recurrent ovarian cancer: is there an impact of FDG PET/CT on patient management?
(Springer, 2010)The aim of this study was to evaluate the clinical value of FDG PET/CT in patients with suspected ovarian cancer recurrence as compared with diagnostic CT, and to assess the impact of the results of FDG PET/CT on treatment ... -
Concomitant endometriosis in malignant and borderline ovarian tumours
(Oxford University Press, 2015)... -
Effects of different drug treatments on the proliferation of human ovarian carcinoma cell line MDAH-2774
(Tubitak Scientific & Technical Research Council Turkey, 2018)Background/aim: In this study, the effects of resveratrol as a natural polyphenol compound, gemcitabine as an antimetabolite that has nucleoside structure analogous to deoxycytidine, and para-aminophenol-derived paracetamol ... -
Hyperthermic intraperitoneal chemotherapy after secondary cytoreduction in epithelial ovarian cancer: A single-center experience
(Lippincott Williams, 2016)... -
Irisin immunostaining characteristics of breast and ovarian cancer cells
(C M B Assoc, 2016)To determine expression pattern of irisin in tissues obtained from human ovarian cancer, breast cancer, and cervix cancer. Tissue samples obtained from subjects with breast cancer, ovarian cancer cervix cancer, simple ... -
Verteporfin mediated sequence dependent combination therapy against ovarian cancer cell line
(Elsevier Science Sa, 2018)Ovarian Cancer is one of the deadliest gynecological cancer showing high resistance to chemotherapy. Non overlapping and synergistic combination therapies are the best option to overcome this multi-pathological silent ...